Catalyst Wire Dossier Catalyst Wire Dossier

Rekovelle

follitropin delta · Ferring Pharmaceuticals
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Rekovelle, covering 2020-12-24 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE) [Phase 2]

See pricing